Literature DB >> 3104454

Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene.

A Weiss, R Shields, M Newton, B Manger, J Imboden.   

Abstract

Concanavalin A (Con A), which together with phorbol myristate acetate (PMA) can activate the human T cell line Jurkat to produce interleukin 2 (IL 2), is shown to depend on the expression of the T3/T cell antigen receptor heterodimer (T3/Ti) complex to induce activation. alpha-methyl mannoside was able to reverse all of the observed effects of Con A on intracellular biochemical events. Therefore, ligand-receptor occupancy appears to be required for sustaining biochemical events associated with triggering the T3/Ti complex. Studies of the time-dependent requirements for the two stimuli required for activation revealed that simultaneous stimulation with both Con A and PMA is required for 2 to 4 hr for the cell to commit itself to activation, as measured by the appearance of secreted IL 2. This 2- to 4-hr requirement correlated precisely with the appearance of IL 2 mRNA, and the appearance of IL 2 transcripts depended on protein synthesis during this critical time period.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104454

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses.

Authors:  A Elbe-Bürger; A M Mommaas; E E Prieschl; E Fiebiger; T Baumruker; G Stingl
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

Review 2.  Structure and function of the T cell antigen receptor.

Authors:  A Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

3.  Distinct temporal programming of naive CD4+ T cells for cell division versus TCR-dependent death susceptibility by antigen-presenting macrophages.

Authors:  Adam G Schrum; Ed Palmer; Laurence A Turka
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

4.  T-cell activation: A queuing theory analysis at low agonist density.

Authors:  J R Wedagedera; N J Burroughs
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

5.  Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation.

Authors:  Reinhard Obst; Hisse-Martien van Santen; Rachel Melamed; Alice O Kamphorst; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

6.  hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation.

Authors:  Jing-Wen Chang; Toru Koike; Makio Iwashima
Journal:  Int Immunol       Date:  2009-10-30       Impact factor: 4.823

7.  Specific inhibition of OKT3-driven T-cell mitogenesis by an anti HLA-class I monoclonal antibody.

Authors:  I Beckman; X Xiaoning; J Bradley
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

8.  Characterization of antigen receptor response elements within the interleukin-2 enhancer.

Authors:  D B Durand; J P Shaw; M R Bush; R E Replogle; R Belagaje; G R Crabtree
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

9.  Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Peter Szigligeti; Lisa Neumeier; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

10.  Dissociation of interleukin-2 production from the cell activation in response to the mitogenic lectin in peripheral CD4+ T cells of LEC mutant rats.

Authors:  T Sakai; T Agui; Y Muramatsu; T Yamada; K Matsumoto
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.